Metabolic dysfunction-associated fatty liver disease: from basic research to clinical application

被引：3
|
作者：
Yang, Ruixu [1 ]
Jin, Qian [1 ]
Fan, Jiangao [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Dept Gastroenterol, Sch Med, Xinhua Hosp, Shanghai 200092, Peoples R China
[2] Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai 200092, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2022年 / 135卷 / 10期
基金：
中国国家自然科学基金;
关键词：
NONINVASIVE TESTS; STEATOHEPATITIS; MAFLD;
D O I：
10.1097/CM9.0000000000002136
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1138 / 1140
页数：3
相关论文
共 50 条
  • [31] Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B
    Huang, Shang -Chin
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (11) : 2148 - 2151
  • [32] Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
    Al Hashmi, Khamis
    Giglio, Rosaria Vincenza
    Stoian, Anca Pantea
    Patti, Angelo Maria
    Al Waili, Khalid
    Al Rasadi, Khalid
    Ciaccio, Marcello
    Rizzo, Manfredi
    FRONTIERS IN NUTRITION, 2024, 11
  • [33] Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Choi, Sung Chul
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    JHEP REPORTS, 2023, 5 (09)
  • [34] Metabolic dysfunction-associated fatty liver disease in people living with HIV
    Michel, Maurice
    Labenz, Christian
    Armandi, Angelo
    Kaps, Leonard
    Kremer, Wolfgang Maximilian
    Galle, Peter R.
    Grimm, Daniel
    Sprinzl, Martin
    Schattenberg, Joern M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [35] Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
    Wang, Xiaolin
    Xie, Qing
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (01) : 128 - 133
  • [36] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E14 - E14
  • [37] Disease severity assessment of metabolic dysfunction-associated fatty liver disease in Taiwan
    Huang, Jee-Fu
    Tsai, Pei-Chien
    Huang, Ching-I
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Dai, Chia-Yen
    Yu, Ming-Lung
    JOURNAL OF HEPATOLOGY, 2022, 77 : S458 - S459
  • [38] Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD)
    Chien, Shih-Chieh
    Chiu, Hung-Chih
    Chiu, Yen-Cheng
    Wang, Ru-Hsueh
    Dillera, Karl Paolo O.
    Lee, Kuo-Ting
    Tsai, Hung-Wen
    Tsai, Yau-Sheng
    Ou, Horng-Yih
    Cheng, Pin-Nan
    DIGESTIVE DISEASES AND SCIENCES, 2025, 70 (03) : 1190 - 1200
  • [39] Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease
    Cheng, Yu-Ming
    Hsieh, Tsung-Han
    Wang, Chia-Chi
    Kao, Jia-Horng
    JHEP REPORTS, 2023, 5 (09)
  • [40] Metabolic Dysfunction-Associated Steatotic Liver Disease and Nonalcoholic Fatty Liver Disease Have Similar Clinical Profiles and Mortality
    Younossi, Zobair
    Paik, James M.
    Golabi, Pegah
    Ong, Janus
    Henry, Linda
    Alqahtani, Saleh
    Nader, Fatema
    DIABETES, 2024, 73
12345